RavenPack Launches Free Coronavirus News Monitor to Help Data-driven Professionals Face the Challenging New Market Conditions

NEW YORK, March 30, 2020 /PRNewswire/ — In response to the coronavirus pandemic, RavenPack, a leading provider of big data analytics, has launched a live and interactive website to help navigate the oceans of information currently available on the novel coronavirus and its impact on world affairs.

The free Coronavirus News Monitor can be accessed on https://coronavirus.ravenpack.com/.

RavenPack decided to release this public dashboard to answer the extraordinary amount of requests from clients looking for data-driven insights to support their decision making during the current uncertain market conditions.

“We wanted to create a more analytical way to track information about the novel coronavirus and to monitor the reactions people are having across the globe, which include things like massive social distancing and panic buying,” said Armando Gonzalez, the Co-Founder, and CEO of RavenPack.

The RavenPack Coronavirus News Monitor is different from other coronavirus dashboards in that it summarizes emotions or sentiments from tens of millions of news articles and public posts into simple indicators, similar to stock tickers.

The guiding principles behind the design of the monitor are based on research performed by the RavenPack Data Science team.  They determined that the sentiment and proportion of global news about topics like “recession fears” often signal the actual impact of real-world events in financial markets, something which RavenPack’s big data platform is uniquely placed to assess.

The monitor contains bespoke indexes uniquely formulated by RavenPack data experts to provide users with added insight and forewarning about changes in the news surrounding the virus – changes that often reflect or foreshadow real-world events.

These include the Contagion Index, which measures the spread of the virus across the media world, the Media Coverage Index, which reflects the proportion of all news that is coronavirus-related, and the Panic Index which provides a gauge of extreme public mood. 

The monitor also features an interactive global map, and tables gauging the sentiment on countries and financial assets, and it can be adapted for those who want a tailored experience.

The creation of bespoke filters by topic, industry, as well for specific portfolios is also available, and users can access the underlying data and/or customize the dashboard to their specific use cases.

About RavenPack

RavenPack is the leading big data analytics provider for financial services. The company’s products allow clients to enhance returns, reduce risk and increase efficiency by systematically incorporating the effects of public information in their models or workflows. RavenPack’s clients include the most successful hedge funds, banks, and asset managers in the world. For more information, please visit www.ravenpack.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/ravenpack-launches-free-coronavirus-news-monitor-to-help-data-driven-professionals-face-the-challenging-new-market-conditions-301031308.html

SOURCE RavenPack

Staff

Recent Posts

Evotec Closes Sale of Just – Evotec Biologics’ Toulouse Site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing…

36 minutes ago

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

4 hours ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

4 hours ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

19 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

19 hours ago